CNS Drugs

Tapentadol in Pain Management: A μ-Opioid Receptor Agonist and Noradrenaline Reuptake Inhibitor
pp. 359-370(12)
Authors: Hartrick, Craig T.; Rozek, Richard J.

Pharmacotherapy for Smoking Cessation: Current Advances and Research Topics
pp. 371-382(12)
Authors: Raupach, Tobias; Onno, Constant P.

Antipsychotic Polypharmacy in Schizophrenia: Benefits and Risks
pp. 383-399(17)
Authors: Barnes, Thomas R.E.; Paton, Carol

Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emerging Concepts Regarding its Mechanism of Action
pp. 401-414(14)
Authors: Lalive, Patrice H.; Neuhaus, Oliver; Benkhoucha, Mahdia; Burger, Danielle; Hohlfeld, Reinhard; Zamvil, Scott S.; Weber, Martin S.

Patterns of Methylphenidate Use and Assessment of its Abuse and Diversion in Two French Administrative Areas Using a Proxy of Deviant Behaviour Determined from a Reimbursement Database: Main Trends from 2005 to 2008
pp. 415-424(10)
Authors: Frauger, Elisabeth; Pauly, Vanessa; Natali, François; Pradel, Vincent; Reggio, Patrick; Coudert, Hervé; Thirion, Xavier; Micallef, Joëlle

Changes in Nursing Burden Following Memantine for Agitation and Aggression in Long-Term Care Residents with Moderate to Severe Alzheimer's Disease: An Open-Label Pilot Study
pp. 425-433(9)
Authors: Herrmann, Nathan; Cappell, Jaclyn; Eryavec, Goran M.; Lanctôt, Krista L.

Dextromethorphan/Quinidine: In Pseudobulbar Affect
pp. 435-445(11)
Author: Garnock-Jones, Karly P.